全文获取类型
收费全文 | 7776篇 |
免费 | 804篇 |
国内免费 | 403篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 9篇 |
妇产科学 | 433篇 |
基础医学 | 102篇 |
口腔科学 | 36篇 |
临床医学 | 323篇 |
内科学 | 143篇 |
皮肤病学 | 38篇 |
神经病学 | 38篇 |
特种医学 | 174篇 |
外科学 | 189篇 |
综合类 | 1408篇 |
预防医学 | 220篇 |
眼科学 | 22篇 |
药学 | 4397篇 |
9篇 | |
中国医学 | 1247篇 |
肿瘤学 | 185篇 |
出版年
2024年 | 23篇 |
2023年 | 81篇 |
2022年 | 181篇 |
2021年 | 257篇 |
2020年 | 246篇 |
2019年 | 196篇 |
2018年 | 195篇 |
2017年 | 242篇 |
2016年 | 298篇 |
2015年 | 273篇 |
2014年 | 769篇 |
2013年 | 580篇 |
2012年 | 768篇 |
2011年 | 736篇 |
2010年 | 544篇 |
2009年 | 479篇 |
2008年 | 478篇 |
2007年 | 505篇 |
2006年 | 384篇 |
2005年 | 342篇 |
2004年 | 251篇 |
2003年 | 184篇 |
2002年 | 152篇 |
2001年 | 132篇 |
2000年 | 126篇 |
1999年 | 88篇 |
1998年 | 54篇 |
1997年 | 50篇 |
1996年 | 36篇 |
1995年 | 41篇 |
1994年 | 33篇 |
1993年 | 16篇 |
1992年 | 24篇 |
1991年 | 10篇 |
1990年 | 13篇 |
1989年 | 15篇 |
1988年 | 25篇 |
1987年 | 21篇 |
1986年 | 20篇 |
1985年 | 11篇 |
1984年 | 27篇 |
1983年 | 11篇 |
1982年 | 7篇 |
1981年 | 11篇 |
1980年 | 16篇 |
1979年 | 13篇 |
1978年 | 6篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1974年 | 3篇 |
排序方式: 共有8983条查询结果,搜索用时 15 毫秒
1.
P. A. Hannan J. A. Khan A. Khan S. Safiullah 《Indian journal of pharmaceutical sciences》2016,78(1):2-7
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form. 相似文献
2.
《Journal of minimally invasive gynecology》2022,29(1):23-40.e7
ObjectiveThe aim was to investigate whether outpatient hysterectomy (OH) has benefits when compared with inpatient hysterectomy (IH) regarding postoperative complications, readmissions, operative outcomes, cost, and patient quality of life.Data SourcesA systematic search for studies comparing OH with IH was conducted through PubMed, SAGE, and Scopus from January 2010 to March 2020, without limitations regarding language and study design.Methods of Study SelectionStudies reporting on the differences between same-day discharge and overnight stay after hysterectomy were included. The study outcomes were overall complication rate, type of complication, readmission after discharge, surgery duration, estimated blood loss, payer savings, hospital savings, and health-related quality of life (HrQoL). Median and range are used to describe non-normal data, while mean ± SD and confidence interval are used to descibe data with normal distribution. A meta-analysis with sensitivity analysis and subgroup analyses was performed.Tabulation, Integration, and ResultsEight studies published between 2011 and 2019 with 104,466 patients who underwent hysterectomy were included in this systematic review and meta-analysis. All included studies except 1 were found to have a high risk of bias. OH in comparison with IH had a lower overall complication rate (odds ratio [OR] 0.70; 95% confidence interval [CI], 0.60–0.82) and lower rates of wound infection (OR 0.60; 95% CI, 0.43–0.84), urinary tract infection (OR 0.64; 95% CI, 0.52–0.78), need for transfusion (OR 0.36; 95% CI, 0.22–0.59), sepsis (OR 0.33; 95% CI, 0.17–0.64), uncontrolled pain (OR 0.79; 95% CI, 0.66–0.95), and bleeding requiring medical attention (OR 0.82; 95% CI, 0.73–0.94). In addition, patients who underwent OH had a lower readmission rate (OR 0.81; 95% CI, 0.75–0.87), surgery duration (standardized mean difference –0.35; 95% CI, –0.61 to –0.08), and estimated blood loss (standardized mean difference –0.63; 95% CI, –0.93 to –0.33) than those who underwent IH. A qualitative analysis found that OH had a poorer patient HrQoL and a lower cost for the hospital as well as the payer.ConclusionOHs present fewer complications and have a lower readmission rate and estimated blood loss as well as a shorter surgery duration than IHs. OHs also have a cost benefit in comparison with IHs. But patients seem to have a worse HrQoL in the first postoperative week after OH. The high risk of bias of the included studies indicates that well-designed clinical trials and standardization of surgical complication reporting are essential to better address this issue. 相似文献
3.
Gynecologic Malignancy-Associated Venous Thromboembolism and Predictive Tool at Thammasat University Hospital
下载免费PDF全文
![点击此处可从《Asian Pacific journal of cancer prevention》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Karit JayasakoonAwassada PunyashthiraBanthisa SomboonJunya PattaraarchachaiKomsun Suwannarurk 《Asian Pacific journal of cancer prevention》2022,23(6):2113-2118
Objectives: Aims were to investigate the prevalence and risk factors of venous thromboembolism (VTE) in gynecologic malignancy cases. Value of screening tool (Caprini) for prediction of VTE was also assessed. Study design: A retrospective study of gynecologic malignancy subjects who underwent major gynecological operation via exploratory laparotomy at Thammasat University Hospital, Pathum Thani, Thailand from January 2015 to December 2020. Participants were categorized into VTE and non-VTE groups. Caprini score, associated laboratory and clinical factors of both groups were evaluated. Results: A total of 392 subjects were recruited into the study. Prevalence of VTE was 7.4 (29/392) percent. VTE was diagnosed in subjects with endometrial, ovarian and cervical cancer at percentage of 7.8 (15/192), 7.9 (11/138) and 5.7 (3/53), respectively. Demographic characters of both groups were comparable. VTE group had significant more Caprini score, platelets count and platelet lymphocyte ratio (PLR) than non-VTE group. Modified Caprini score (2 multiply Caprini score plus 1 multiply PLR) was generated for better VTE prediction. Sensitivity and specificity of Caprini (≥5.5) and modified Caprini scores (≥22.8) were 72.4 vs 39.4, and 79.3 vs 52.1 percent, respectively. Conclusion: Prevalence of VTE among gynecologic malignancy cases was 7.4 percent. The modified Caprini score was an alternative VTE predictive tool. Cut-off point of modified Caprini score at equal or more than 22.8 was proposed. 相似文献
4.
目的:探讨美托洛尔(β1受体阻滞剂)用于老年COPD合并冠心病史治疗的临床疗效。方法:选取2018年6月—2019年6月在我院接受治疗的60岁以上(包括60岁)COPD合并冠心病史老年患者,分为对照组与观察组。对照组给予接受布地奈德福莫特罗粉吸入剂治疗,观察组在使用布地奈德福莫特罗粉吸入剂治疗的基础上口服琥珀酸美托洛尔缓释片治疗,观察对比两组治疗效果。结果:观察组临床治疗效果优于对照组,观察组住院时长以及并发症的发生率低于对照组(P<0.05),差异具有统计学意义。结论:老年COPD合并冠心病史接受美托洛尔治疗,可有效缩短住院时长、用药效果明显、有效提升用药安全性,值得临床推广。 相似文献
5.
6.
7.
通过对口腔崩解片的特点及主要制备工艺的分析,结合当前中成药工业的现状及具体实际,认为口腔崩解片可以应用于中成药制剂的开发。 相似文献
8.
目的 探讨自制苏芪合剂对Ⅲ~Ⅳ级IgA肾病患者的疗效及患者T细胞功能的改善.方法 28例Ⅲ~Ⅳ级IgA肾病患者随机分为两组,对照组:醋酸泼尼松-日1mg,kg,隔日晨起顿服,盐酸苯那普利-日10mg;治疗组:在上述用药的基础上加用自制苏芪合剂.8周后,观察患者缓解率、T细胞功能及不良反应.结果 治疗组患者在缓解率、T细胞功能改善等方面优于对照组,且因糖皮质激素的使用而出现的不良反应少于对照组.结论 苏芪合剂联合治疗Ⅲ~Ⅳ级IgA肾病疗效显著并能有效改善T细胞功能. 相似文献
9.
高效液相色谱法测定石杉碱甲片的含量 总被引:2,自引:0,他引:2
采用高效液相色谱法测定石杉碱甲片的含量。固定相为μBondapak C18,流动相为乙腈-0.02mol/L磷酸二氢钾溶液(12:88),以对乙酰氨基酚为内标,石杉碱甲浓度在10 ̄50mg/L范围内与峰面积呈良好的线性关系,平均回收率为99.93%,RSD为0.41%(n=9)。 相似文献
10.
妇科腹腔镜手术几种激光对兔子宫壁损伤的实验研究 总被引:2,自引:2,他引:0
为掌握妇科腹腔镜手术所应用的激光器的治疗剂量,对几种激光引起的兔子宫壁热损伤进行观察。实验研究证实:所有激光产生的损伤程度与所用的剂量呈正相关。术后48h与即刻损伤程度相比,半导体激光的损伤程度明显加深、加宽;但CO2激光和NdYAG激光接触式光刀无显著变化。说明应用激光行妇科腹腔镜手术治疗时,所产生的损伤与应用的功率密度有关,为临床合理选用腹腔镜下的激光治疗提供依据 相似文献